Showing results (251-260 of 372) with videos related to

Sort By:
Pageof 38
Medcomm|February 27, 2026
Real-Time MRI With Deep Learning for Efficient Evaluation of Neuromuscular Breathing ImpairmentRachel Zeng, Omar Al-Bourini, Leonie Lettermann, et al.
BMJ Open|July 14, 2023
Development of an interprofessional person-centred care concept for persons with care needs living in their own homes (interprof HOME): study protocol for a mixed-methods studyBritta Tetzlaff, Martin Scherer, Katrin Balzer, et al.
Frontiers in Neurology|April 12, 2019
ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral SclerosisPaul Lingor, Markus Weber, William Camu, et al.
European Journal of Heart Failure|March 30, 2019
Exercise training in patients with a left ventricular assist device (Ex-VAD): rationale and design of a multicentre, prospective, assessor-blinded, randomized, controlled trialAnna Bobenko, Felix Schoenrath, Jan H Knierim, et al.
BMC Palliative Care|December 20, 2024
Effects of timely case conferencing between general practitioners and specialist palliative care services on symptom burden in patients with advanced chronic disease: results of the cluster-randomised controlled KOPAL trialTina Mallon, Josefine Schulze, Nadine Pohontsch, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 16, 2024
[Structured triage in the emergency department via intelligent assistant service OPTINOFA : Results of a multicenter, cluster-randomized and controlled interventional study in Germany]Sabine Blaschke, Harald Dormann, Rajan Somasundaram, et al.
ESC Heart Failure|November 30, 2020
Reporting and interpretation of subgroup analyses in heart failure randomized controlled trialsMuhammad Shahzeb Khan, Muhammad Arbaz Arshad Khan, Simra Irfan, et al.
European Heart Journal|August 26, 2024
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trialStephan von Haehling, Wolfram Doehner, Ruben Evertz, et al.
Nature Medicine|May 10, 2026
The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.
Age and Ageing|May 24, 2024
Evaluating palliative care case conferences in primary care for patients with advanced non-malignant chronic conditions: a cluster-randomised controlled trial (KOPAL)Tina Mallon, Josefine Schulze, Judith Dams, et al.
Pageof 38